J&J Files 8-K Detailing Financials and Notes

Ticker: JNJ · Form: 8-K · Filed: 2025-04-15T00:00:00.000Z

Sentiment: neutral

Topics: debt, financials

TL;DR

J&J dropped an 8-K showing off their debt structure - lots of notes due in the next few decades.

AI Summary

Johnson & Johnson filed an 8-K on April 15, 2025, reporting on its Results of Operations and Financial Condition, as well as other events and financial statements. The filing details various notes due in the coming years, including $1.150 billion in notes due November 2028 and $3.600 billion in notes due February 2045.

Why It Matters

This filing provides investors with updated financial information and details on Johnson & Johnson's outstanding debt obligations, offering transparency into the company's financial structure.

Risk Assessment

Risk Level: low — This is a routine financial filing providing information on existing debt and financial condition, not indicating new or significant risks.

Key Numbers

$1.150B — Notes Due November 2028 (Part of J&J's outstanding debt)
$2.700B — Notes Due February 2029 (Part of J&J's outstanding debt)
$3.200B — Notes Due November 2032 (Part of J&J's outstanding debt)
$3.050B — Notes Due February 2033 (Part of J&J's outstanding debt)
$1.650B — Notes Due 2035 (Part of J&J's outstanding debt)
$3.350B — Notes Due November 2036 (Part of J&J's outstanding debt)
$3.350B — Notes Due February 2037 (Part of J&J's outstanding debt)
$3.550B — Notes Due November 2044 (Part of J&J's outstanding debt)

Key Players & Entities

JOHNSON & JOHNSON (company) — Filer
20250415 (date) — Filing Date
$1.150 billion (dollar_amount) — Notes due November 2028
$3.600 billion (dollar_amount) — Notes due February 2045

FAQ

What is the total principal amount of notes due in 2028?

The filing indicates $1.150 billion in notes due November 2028.

When are the largest principal amount of notes due according to this filing?

The largest principal amount of notes listed is $3.700 billion due February 2055.

What is the filing date of this 8-K?

The filing date is April 15, 2025.

What are the main items reported in this 8-K?

This 8-K reports on Results of Operations and Financial Condition, Other Events, and Financial Statements and Exhibits.

What is the SIC code for Johnson & Johnson?

The Standard Industrial Classification (SIC) code for Johnson & Johnson is 2834, Pharmaceutical Preparations.

From the Filing

0000200406-25-000110.txt : 20250415 0000200406-25-000110.hdr.sgml : 20250415 20250415081419 ACCESSION NUMBER: 0000200406-25-000110 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 21 CONFORMED PERIOD OF REPORT: 20250415 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250415 DATE AS OF CHANGE: 20250415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 25837644 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20250415.htm 8-K jnj-20250415 0000200406 false 0000200406 2025-04-15 2025-04-15 0000200406 us-gaap:CommonStockMember 2025-04-15 2025-04-15 0000200406 jnj:A1.150NotesDueNovember2028Member 2025-04-15 2025-04-15 0000200406 jnj:A2.700NotesDueFebruary2029Member 2025-04-15 2025-04-15 0000200406 jnj:A3.20NotesDueNovember2032Member 2025-04-15 2025-04-15 0000200406 jnj:A3.050NotesDueFebruary2033Member 2025-04-15 2025-04-15 0000200406 jnj:A1.650NotesDue2035Member 2025-04-15 2025-04-15 0000200406 jnj:A3.350NotesDueNovember2036Member 2025-04-15 2025-04-15 0000200406 jnj:A3.350NotesDueFebruary2037Member 2025-04-15 2025-04-15 0000200406 jnj:A3.550NotesDueNovember2044Member 2025-04-15 2025-04-15 0000200406 jnj:A3.600NotesDueFebruary2045Member 2025-04-15 2025-04-15 0000200406 jnj:A3.700NotesDueFebruary2055Member 2025-04-15 2025-04-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  April 15, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 2.700% Notes due February 2029 JNJ29B New York Stock Exchange 3.200% No